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1  | INTRODUC TION
Antibodies against citrullinated proteins (ACPA) and IgG-Fc (rheu-
matoid factor, RF) are a hallmark of rheumatoid arthritis (RA). 
Seropositivity for these autoantibodies can be detected years before 
clinical disease onset (Malmström, Catrina, & Klareskog, 2017), and 
the presence of ACPA in RA is associated with worse disease out-
come (van der Helm-van Mil, Verpoort, Breedveld, Toes, & Huizinga, 
2005). The aetiology of immune dysregulation and autoimmunity in 
RA is still unclear, but is presumed to be initiated at inflamed mucosal 
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Abstract
Aim: To assess rheumatoid arthritis (RA)-associated autoantibodies in the gingivocre-
vicular fluid (GCF) of RA patients and healthy controls with or without periodontal 
disease, as chronic mucosal inflammation in periodontal disease is hypothesized to 
contribute to the formation of these autoantibodies.
Materials and methods: Anti-citrullinated protein antibodies (ACPA), rheumatoid fac-
tor (RF), and their IgA isotypes were assessed in the serum and GCF of RA patients 
(n = 72) and healthy controls (HC, n = 151). The presence and levels of these antibod-
ies were studied in relation to interleukin (IL)-8 and periodontal disease.
Results: In contrast to the HC, the levels of ACPA and RF in the serum and GCF of 
the RA patients were strongly correlated (p < .0001). The HC with high levels of IgA-
ACPA (n = 27) also had significantly higher levels of total IgG, total IgA, and IL-8 in 
the GCF than the HC with low levels of IgA-ACPA in the GCF (n = 124). Periodontal 
inflammation and smoking were seen more frequently in the group with high levels 
of IgA-ACPA compared to the group with low IgA-ACPA.
Conclusion: The IgA-ACPA in the GCF of HC may be associated with periodontal 
inflammation and smoking, and could be involved in the progression to RA.
K E Y W O R D S
anti-citrullinated protein autoantibodies, mucosal inflammation, rheumatoid arthritis, 
rheumatoid factor
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surfaces, specifically the mucosal surfaces of the lungs and oral cav-
ity (i.e. the periodontium), in combination with genetic and environ-
mental factors such as smoking (Mikuls, Payne, Deane, & Thiele, 
2016).
Periodontal disease is primarily triggered by bacterial infection 
and leads to inflammation and destruction of the periodontium. 
Smoking leads to increased susceptibility to, greater severity and 
faster progression of periodontal disease (Nociti, Casati, & Duarte, 
2015). Besides local tissue destruction, the continuous low-grade in-
flammation may, partly because of hyperreactive neutrophils (Ling, 
Chapple, & Matthews, 2015), have systemic consequences. The 
established bidirectional association between the existence and/or 
severity of periodontal disease and systemic (autoimmune) diseases 
such as RA (Kumar, 2016; Smit et al., 2012) can be explained by, 
amongst others, shared risk factors like genetic predisposition and 
smoking, a higher local and systemic inflammatory burden as well as 
by the induction of autoimmunity by chronic inflammation (Potempa, 
Mydel, & Koziel, 2017). However, ACPA seropositivity was found to 
be rather low in patients with periodontal disease without RA (de 
Pablo et al., 2014; Janssen et al., 2015), whereas their RF seroposi-
tivity was slightly higher (Janssen et al., 2015; Thé & Ebersole, 1991).
Citrullination is catalysed by endogenous peptidyl arginine deimi-
nase (PAD) enzymes in neutrophils and monocytes, and is thought to 
play an important role in RA. PAD is also essential for antibacterial 
innate immunity mediated by forming neutrophil extracellular traps 
(NETs), in the form of highly decondensed chromatin structures. 
Histone hypercitrullination catalysed by PAD4 correlates with chro-
matin decondensation during NET formation (Li et al., 2010). NETs 
have been implicated in a number of autoimmune conditions, includ-
ing RA, but also in periodontal disease. As PAD enzymes are not 
only necessary for NET formation but also for ACPA formation, it 
is interesting to hypothesize that their activity may link the two dis-
eases together (Cooper, Palmer, & Chapple, 2013). Another potential 
mechanistic link between periodontal disease and RA comes from 
the discovery that the periodontal pathogen Porphyromonas gingi-
valis has the unique ability to express its own PAD enzyme (PPAD), 
which led to the hypothesis that the breakdown in the tolerance to 
citrullinated proteins is initiated by PPAD dependent citrullination 
(Rosenstein, Greenwald, Kushner, & Weissmann, 2004; Wegner 
et al., 2010). An Aggregatibacter actinomycetemcomitans periodontal 
infection could be another mechanistic link to initiating autoimmu-
nity in RA. Aggregatibacter actinomycetemcomitans leukotoxin (LtxA) 
is able to dysregulate the activation of PAD enzymes in host neutro-
phils leading to the release of hypercitrullinated proteins, thereby 
mimicking the repertoire of citrullinated antigens found in the RA 
joint (Konig et al., 2016).
Gingival crevicular fluid (GCF), the periodontal exudate, can be 
collected from the gingival crevice around the teeth. It is composed 
of serum and locally generated components. Leakage of GCF in-
creases when the gingival crevice becomes inflamed (Champagne 
et al., 2003). Although it is hypothesized that a chronically inflamed 
periodontium is a potential site at which immune tolerance to citrul-
linated epitopes is broken and the production of ACPA begins, the 
presence of ACPA in GCF has hardly been investigated even though 
older studies show that RF is present and produced in inflamed peri-
odontal tissue (Gargiulo, Robinson, Toto, & Gargiulo, 1982; Hirsch, 
Tarkowski, Koopman, & Mestecky, 1989). We know that inflamed 
periodontal tissue as well as the GCF of periodontally inflamed sites 
contains citrullinated peptides (Hendler et al., 2010; Nesse et al., 
2012; Schwenzer et al., 2017). Tissue expression of citrullinated pro-
teins and the expression of PAD2 and 4, which are important in RA, 
increase with inflammation severity (Harvey et al., 2013). In addition, 
the activity of PAD and PPAD in GCF increases in the presence of 
periodontal disease (Laugisch et al., 2016). Up to now, only Harvey 
et al. (2013) demonstrated the presence of ACPA in the GCF of some 
patients with periodontal disease. There are no reports of ACPA, RF 
or other RA-associated autoantibodies in RA patients' GCF (Rahajoe, 
de Smit, Kertia, Westra, & Vissink, 2019). Therefore, the aim of this 
study was to assess RA-associated autoantibodies, especially the IgA 
isotypes of ACPA and RF because they are specific for mucosal in-
flammation in the GCF of RA patients and in healthy controls with or 
without periodontal disease. The presence of these RA-associated 
autoantibodies is related to the total periodontal inflamed surface 
area (PISA; Nesse et al., 2008), as well as to the local presence of 
the chemokine interleukin-8, as a chemoattractant for neutrophils, 
important for inducing NET formation (Gonzalez-Aparicio & Alfaro, 
2019).
2  | MATERIAL S AND METHODS
Rheumatoid arthritis patients (n = 72) were consecutively re-
cruited at the outpatient Rheumatology Clinic, Sardjito Hospital, 
University of Gadjah Mada in Yogyakarta, Indonesia between 
June 2014 and June 2015. The inclusion criteria were fulfilling the 
ACR (American College of Rheumatology) classification criteria 
for RA 2010 (Aletaha et al., 2010). The exclusion criteria were as 
Clinical Relevance
Scientific rationale for the study: Mucosal inflammation in 
periodontal disease has been hypothesized to contribute 
to autoimmunity in RA. Arthritis autoantibodies can be 
present years before clinical disease presentation, and 
there is ample evidence that these autoantibodies are pre-
sent in the periodontium.
Principal findings: In contrast to the RA patients, arthritis 
autoantibodies were present in the GCF but not in the 
serum of the healthy controls, implicating local induction 
of these autoantibodies. In the healthy controls, this was 
related to periodontal inflammation and smoking.
Practical implications: Mucosal inflammation, due to peri-
odontal disease and smoking, could be involved in RA 
development.
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follows: under 18 years of age, edentulism, diabetes, cardiovascu-
lar disease with anti-coagulant medication, presence of non-oral 
infection, antibiotic use <3 months prior the study, presence of 
malignancy, and pregnancy including a 6-month post-partum pe-
riod as well as breastfeeding. Consecutive healthy controls (HC, 
with and without periodontal disease; n = 151) were selected from 
the patients with an appointment for a first consultation for third 
molar assessment or tooth extraction at the Oral and Maxillofacial 
Surgery Clinic, Sardjito Hospital or Dental hospital, Gadjah Mada 
University in Yogyakarta, Indonesia. Inclusion criteria were not 
suffering from RA and the absence of distinct oral pathology other 
than periodontal disease (such as cysts, abscesses not due to peri-
odontal disease and a tumour). The same exclusion criteria applied 
as for the RA patients. This study was reviewed and approved by 
the Medical and Health Research Ethics Committee of the Medical 
Faculty of Gadjah Mada University, Yogyakarta, Indonesia accord-
ing to the Declaration of Helsinki 2008 (Ref: KE/FK/430/EC). All 
the patients were informed verbally and by letter, and the partici-
pants provided written informed consent. We aimed for a larger 
recruitment (1:2) of the control group to allow for a more reliable 
comparison and to be able to correct for potential confounders.
2.1 | Clinical examination
The RA patients were clinically examined by a rheumatologist (DW 
and KN) during their routine visit at the outpatient rheumatology 
clinic. RA disease activity was measured using the Disease Activity 
Score 28 joint count (DAS28-ESR; Prevoo et al., 1995). The other 
recorded parameters included RA disease duration, smoking status 
(current, former or never), and RA medication. After inclusion, both 
the RA patients and healthy controls underwent clinical periodon-
tal examination by trained and calibrated dentists (MT and AM). 
Full-mouth oral measurements at 6 sites per tooth (pocket probing 
depth, bleeding on probing, and periodontal attachment loss) were 
recorded to calculate the PISA. PISA reflects the extent of inflam-
matory burden due to periodontal inflammation (Nesse et al., 2008). 
A PISA value ≥130 mm2 has been shown to be associated with the 
Centers for Disease Control and Prevention—American Academy of 
Periodontology (CDC-AAP) case definition of periodontitis (Leira, 
Martín-Lancharro, & Blanco, 2018).
2.2 | Sampling
Venous blood was collected from all the participants on the day of 
their (periodontal) examination, and the erythrocyte sedimentation 
rate (ESR) was measured using the Wintrobe Method. After centrifu-
gation, the serum was stored at −20°C until further analysis. GCF 
samples were taken from the deepest non-bleeding site per quad-
rant based on the pocket probing depth measurements. The sample 
sites were isolated with cotton rolls, and supragingival plaque was 
carefully removed with curettes and cotton pallets. Subsequently, 
two sterile paper points (Inline, BM Dentale) were inserted per site 
and left in for 10 s. Any GCF samples visibly contaminated with 
blood were discarded. The GCF samples were pooled per patient, 
wrapped in aluminium foil and stored in a sterile sample cup (1.5 ml, 
Stardec, TG Medical) at −20°C. The GCF analysis involved eluting 
the paper points overnight at 4°C in 200 µl phosphate-buffered sa-
line (PBS) with 1% bovine serum albumin (BSA), using three paper 
points per elution. After centrifugation at 1,550 g for 20 min, the 
paper points were removed and the supernatants were stored at 
−20°C until further analysis.
2.3 | Laboratory procedures
Total IgG and IgA in the GCF were determined by ELISA using the 
following protocol: 96 well plates (Corning® Costar®, Sigma-Aldrich) 
were coated with donkey F(ab)2 anti-human IgG (1:5,000; Jackson) 
or mouse anti-human IgA (1:1,500; Temecula) and incubated over-
night at room temperature (RT). Standard curves were constructed 
for both isotypes using the Siemens N protein standard SL starting 
at 50 ng/ml for IgG and 300 ng/ml for IgA. Fourfold dilutions were 
made of the IgG and the IgA from the GCF, starting at 1:100 for IgG 
and 1:5 for IgA and were incubated for 1.5 hr at RT. Mouse anti-
human IgG-HRP (1:2,000) and goat anti-human IgA-HRP (1:4,000; 
both Southern Biotech) conjugates were added to the dilutions for 
1 hr at RT. A colour reaction was established using tetramethylben-
zidine (Sigma-Aldrich) and hydrogen peroxide.
IgG anti-cyclic citrullinated protein antibody (anti-CCP) levels 
were measured using a commercial anti-CCP2 kit (Euro Diagnostica) 
according to the manufacturer's protocol, with a diagnostic cut-off 
positivity value of >10 U/ml. Serum samples with a value <10 U/
ml were measured again with an adjusted protocol whereby the 
samples were diluted 1:10 instead of 1:50. IgA anti-CCP was mea-
sured using a modified anti-CCP2 kit (Janssen et al., 2015) with a 
goat anti-human IgA-HRP (Southern Biotech)—conjugate dilution of 
1:2,000. IgA seropositivity was defined as >2 SD above the mean of 
the healthy controls without periodontal disease and who had never 
smoked (n = 88). Both the IgG and IgA isotypes from the GCF sam-
ples were diluted 1:10.
The IgM and IgA RFs were determined in the serum and GCF 
using an in-house validated ELISA (Van Leeuwen, Westra, van Riel, 
Limburg, & Van Rijswijk, 1995), with minor modifications: 96 well 
plates (Corning® Costar®, Sigma-Aldrich) were coated with 40 µg/ml 
heat-aggregated human IgG diluted in 0.1 M carbonate buffer and 
incubated overnight at RT. The GCF samples were diluted 2:1 in the 
plate and incubated for 1 hr at RT. Goat anti-human IgM-HRP or IgA-
HRP (both Southern Biotech) was added for 30 min at RT. A colour 
reaction was established using tetramethylbenzidine and hydrogen 
peroxide. The levels were expressed in international units (IU) per 
millilitre, and seropositivity was defined as >5 IU/ml for IgM RF and 
>25 IU/ml for IgA RF. Absorbance was read at 450 nm in a VersaMax 
microplate reader and antibody levels were calculated using the 
SoftMax PRO software (both Molecular Devices).
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IL-8 in the GCF was measured by a DuoSet ELISA (DY208, 
R&Dsytems, Bio-Techne) according to the manufacturers' instruc-
tions. The GCF samples were measured in 1:5 and 1:25 dilutions.
2.4 | Statistics
Statistical analyses were performed using the GraphPad Prism 
software (version 8 for Windows; GraphPad software). Data were 
non-normally distributed (based on QQ plots). Regarding group com-
parisons, a Mann–Whitney U test was used for continuous variables 
and Fisher's exact test for categorical variables. Since the RA pa-
tients and HC were not directly matched, it was not necessary to 
take the unequal group size into account in the statistical compari-
son at group level. Correlations between different parameters were 
assessed by Spearman's ρ.
3  | RESULTS
Seventy-two RA patients and 151 HC were analysed. The patient 
characteristics are listed in Tables 1 and 2. The RA patients comprised 
more women and fewer smokers than the HC. The median number of 
teeth was high in both groups (median: 26 for RA and 28 for HC); how-
ever, the overall number of teeth in the RA patients was slightly lower. 
Although the median RA disease activity was high (DAS28 5.3), the se-
ropositivity for ACPA and RF in the RA patients was rather low (40% 
for IgG ACPA, 39% for IgA-ACPA, 47% for IgM RF, and 35% for IgA RF). 
Seropositivity in the HCs was significantly lower (1.3% for IgG ACPA, 
6.0% for IgA-ACPA, 2.6% for IgM RF, and 0% for IgA RF). PISA in The 
HC and RAs was not significantly different. There were no differences 
in the prevalence of periodontal disease between the groups (Table 2). 
DAS28 was negatively correlated with the number of teeth (p = .017).
The ACPA or RF levels in the RA patients' serum were not related 
to the presence of periodontal disease. Although the overall levels 
of these autoantibodies were low in the HC serum, IgA-ACPA was 
slightly higher in those with periodontal disease (p = .042; Figure 1a).
Anti-citrullinated protein antibodies and RF were present in the 
GCF (Figure 1b). The IgA-ACPA levels were significantly higher in the 
GCF of the HC (p = .0043), while the RA patients had significantly 
higher IgG ACPA and IgM RF levels in the GCF (both p < .0001). The 
IgA RF levels were slightly higher in the RA patients' GCF (p = .0207). 
Total IgG and total IgA in the GCF had increased significantly in the 
groups with periodontal disease compared to the groups without 
periodontal disease (RA: p < .0002 for IgG and p < .0073 for IgA, HC: 
p < 0001 for IgG, p < .0005 for IgA), while only the HC periodontal 
disease group had higher levels of IL-8 (p = .0204; Figure 2).
In this study, we found higher levels of IgA-ACPA in the GCF 
of the HC, whereas the IgA RF levels were comparable among the 
groups. When calculating the ratios of IgA-ACPA and total IgA as 
well as IgA RF and total IgA in the GCF, we found that the RA pa-
tients' average ACPA/IgA ratio was 1.089 U/µg and the RF/IgA ratio 
TA B L E  1   Patient characteristics
Patient characteristics RA (n = 72) HC (n = 151) p value
Age (median, IQR) 48 (40–55) 45 (34–53) .0583
Female (%) (n) 89 (64) 47 (71) <.0001




0 (0) 4.0 (6) .1805
Hypertension 
(+medication)
9.7 (7) 4.6 (7) .1515
Medication for hypertension, also combinations (n)
Calcium channel 
blocker
5 5  
Ace inhibitor 2 2  
Angiotensin 
receptor blocker
1 0  
RA characteristics
Disease duration in 
months (median, 
IQR)







(DAS28 < 2.6) (%) (n)
0 (0)   
Low disease activity 
(DAS28 ≥ 2.6 < 3.2) 
(%) (n)
4.2 (3)   
Moderate 
disease activity 
(DAS28 ≥ 3.2 < 5.1) 
(%) (n)
36 (26)   
High disease activity 
(DAS28 ≥ 5.1) (%) (n)
60 (43)   
ACPA seropositive (%) (n)
IgG (>10 U/ml) 40 (29) 1.3 (2) <.0001
IgAb  (>1.2 U/ml) 39 (28) 6.0 (9) <.0001
RF seropositive (%)
IgM (>5 IU/ml) 47 (34) 2.6 (4) <.0001
IgA (>25 IU/ml) 35 (25) 0 (0) <.0001
Medication for RA (%) (n), also combinations
No/herbal 14 (10)   
NSAID 63 (45)   
Steroid 78 (56)   
DMARDS total 57 (41)   
DMARDS specific
MTX 46 (33)   
Leflunomide 2.8 (2)   
Chloroquine 2.8 (2)   
Sulfasalazine 17 (12)   
aAccording to (Wells et al., 2009). 
b>2 SD above the mean of non-smoker healthy controls without 
periodontal disease, n = 88. 
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was 0.691 U/µg, while in the HC they were ACPA/IgA: 12.378 U/µg 
and RF/IgA: 0.541 U/µg. Thus, when relating the autoantibody levels 
to total IgA, the IgA-ACPA in the GCF of the HC seems to be over 
represented compared with IgA RF. When looking at the individuals 
with high (>0.1 U/ml) IgA-ACPA (n = 27) or low (<0.1 U/ml) IgA-ACPA 
(n = 124), it was found that there were several differences. Although 
the PISA difference was borderline between these groups (p = .058), 
the total levels of IgG and IgA in the GCF were higher in the IgA-
ACPA high group (p = .0066 and 0.0084, respectively).
The relationship between the PISA and IgA-ACPA in the GCF 
may be also reflected by the higher prevalence of IgA-ACPA (>0.1 U/
ml) in the HC with periodontal disease (25%) than without periodon-
tal disease (15%; Figure 1c). The HC smokers tended to have higher 
levels of IgA-ACPA in the GCF than the non-smokers (26% vs. 15%).
The ACPA and RF levels in the RA patients' serum and GCF were 
highly correlated (p < .0001 for all antibodies), in contrast to the HC 
(only slightly significant for IgA-ACPA, p = .050). All the participants' 
total IgG and total IgA were highly inter-correlated (p < .0001). The 
total IgG, total IgA, and IL-8 in the GCF were most strongly cor-
related with the PISA of the HC (p < .0001 for total IgG and total 
IgA, p = .0042 for IL-8), which is also reflected in Figure 2.
4  | DISCUSSION
This study is the first to assess the IgA isotypes of ACPA and RF 
in the periodontal exudate (GCF) from a large cohort of Indonesian 
RA patients and Indonesian individuals without RA (HC). The preva-
lence of periodontal inflammation was equal between these groups. 
As expected, the seropositivity of ACPA and RF was higher in the RA 
patients. Regarding GCF, however, the IgA isotype of the ACPA was 
higher in the HC, whereas the IgG isotype of the ACPA was higher 
in the GCF of the RA patients. Since the ACPA and RF levels in the 
RA patients' GCF were highly correlated to the levels in the serum, 
the presence of these autoantibodies in the GCF may partially be 
derived from the circulation. There were no correlations found be-
tween autoantibodies in serum and GCF in the HC. These observa-
tions indicate that IgA-ACPA may have been induced locally in the 
HCs' mucosal periodontal tissues.
We showed previously that the levels of RA autoantibodies 
(ACPA and RF) of the IgA isotype in the serum of non-RA patients 
with mucosal inflammation, such as bronchiectasis, cystic fibrosis, 
and periodontal disease, were higher compared to those of healthy 
people (Janssen et al., 2015). Several studies have investigated the 
use of measuring the isotypes of the RA autoantibodies in RA risk 
and RA patients. In general, testing for multiple ACPA specifici-
ties and more isotypes increases the possibility of predicting RA 
and increases the diagnostic power of autoimmune serology (Brink 
et al., 2016; Sieghart et al., 2018). Ärlestig et al. (2012) found that 
first-degree relatives of RA patients have a higher relative distri-
bution of IgA and IgM ACPA isotypes than IgG, whereas the IgG 
isotype dominates in patients with RA. Another study looked at 
ACPA isotypes and secretory IgA (S-IgA) ACPA levels in the serum 
of recent-onset RA patients, with a 3-year follow-up (Kastbom 
Periodontal characteristics RA (n = 72) HC (n = 151) p value
Number of teeth (median, IQR) 26 (22–28) 28 (25–30) .0003
PISA in mm2 (median, IQR) 4.9 (0–98) 11 (0–186) .42
Periodontal disease (%) (n) according to 
cut-off of PISA ≥ 130 mm2a 
21 (15) 29 (44) .1992
% of sites with pocket probing depth 1–2 mm (median, IQR)
All 95 (74–99) 92 (66–100)  
With periodontal disease 56 (42–71) 55 (35–68)  
Without periodontal disease 97 (94–99) 98 (91–100)  
% of sites with pocket probing depth 3–4 mm (median, IQR)
All 4.7 (0.8–24) 6.2 (0–27)  
With periodontal disease 41 (27–44) 36 (21–45)  
Without periodontal disease 2.3 (0.6–6.1) 1.7 (0–7.9)  
% of sites with pocket probing depth ≥5 mm (median, IQR)
All 0 (0–0.5) 0 (0–3.8)  
With periodontal disease 3.8 (1.1–13) 6.5 (2.8–15)  
Without periodontal disease 0 (0–0) 0 (0–0)  
% of sites with bleeding on probing (median, IQR)
All 1.1 (0–9.8) 1.3 (0–13)  
With periodontal disease 35 (18–57) 31 (15–45)  
Without periodontal disease 0.6 (0–2.0) 0 (0–2.5)  
aA PISA value ≥130 mm2 has been shown to be associated with the CDC-AAP case definition of 
periodontitis (Leira et al., 2018). 
TA B L E  2   Periodontal characteristics
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F I G U R E  1   ACPA and RF in the serum 
(a) and GCF (b) of RA patients and healthy 
controls (HC) with or without periodontal 
disease (PD) (c). Lines represent medians. 
*p < .05, **p < .01, ***p < .0001
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et al., 2018). It was reported that the S-IgA and IgM ACPA levels 
declined rapidly with anti-rheumatic therapy and correlated with 
decreased disease activity, indicating that the down-regulation of 
mucosal immunity to citrullinated proteins or peptides may be a 
key feature of therapy response in early RA. Finally, salivary IgA 
anti-cyclic citrullinated protein (CCP) was measured in unstimu-
lated salivary samples from 63 patients with established RA and 
from 20 healthy people (Svärd, Kastbom, Sommarin, & Skogh, 
2013). Salivary IgA anti-CCP was found in 14/63 (22%) patients 
and one (5%) control, and was associated with a less severe out-
come of RA. Hence, relatively higher levels of IgA-ACPA are seen 
in pre- and recent-onset RA patients than IgG ACPA, and may be 
predictive of RA development and severity. Of note, Aleyd, Al, 
Tuk, van der Laken, and van Egmond (2016) demonstrated that 
IgA complexes in the plasma and synovial fluid of patients with 
RA induce neutrophil extracellular traps via FcaRI, indicating that 
IgA autoantibodies may play a role in hypercitrullination, induced 
by NETs.
Recently Holers et al. (2018) published an interesting review dis-
cussing the mucosal origin theory: protection turns to destruction. 
In their conclusion, they state that IgA-ACPA plays an important role 
in the local protective immune response, outside its eventual causal 
relationship with inflammatory arthritis. Many potential factors in 
the mucosa, as well as systemic alterations, could influence both the 
local initiation and systemic expansion of ACPA expression. Holers 
et al. (2018) stated that a likely major driver of early disease initiation 
is the loss of the mucosal barrier which, here, concerns the oral mu-
cosa in relation to periodontal disease.
The extent of periodontal inflammation in our study was quan-
tified by the PISA. The high correlation between total IgG and total 
IgA in the GCF with the PISA in all the participants underlines that 
the PISA is a good clinical measure for quantifying the burden of 
periodontal inflammation. As radiographic assessment is necessary 
to confirm periodontal diagnosis, PISA does not reflect periodontal 
diagnosis. Therefore, the division in presence or absence of peri-
odontitis according to the cut-off values is somewhat artificial. In 
addition, prevalence of periodontitis according to PISA values was 
relatively low in our study groups.
The correlation of IL-8 with PISA in the HC supports the impor-
tance of neutrophil involvement in periodontal inflammation (Ling 
et al., 2015). The presence of RA, or RA medication, may have over-
shadowed this relationship in the RA patients. In addition, the rela-
tionships between IgA-ACPA in the GCF, PISA, and IL-8 in the HC 
may point towards the involvement of hypercitrullination and NET 
formation in these neutrophils (Cooper et al., 2013). As mentioned 
previously, IL-8 may play a role in attracting neutrophils and later in 
inducing NET formation (Gonzalez-Aparicio & Alfaro, 2019). Another 
factor influencing citrullination and ACPA induction is smoking 
(Sakkas, Bogdanos, Katsiari, & Platsoucas, 2014). In our study, the 
influence of smoking was reflected by the high IgA-ACPA in the GCF 
of the HC smokers compared with the HC who had never smoked.
Although disease activity was high in the RA patients of our 
study population, their seropositivity for ACPA and RF was rather 
low, which can be regarded as a limitation of this study. ACPA and RF 
seropositivity has been reported to be comparable between Asian 
and Western populations (around 60%–80%; Barra et al., 2014; 
Chun-Lai et al., 2011; Terao et al., 2015). Our population was of 
Indonesian decent and many more men than women smoke, which 
may explain that fewer smokers were present in the RA group, and 
also that the prevalence of periodontal disease was not different be-
tween the RA patients and the HC. The high RA disease activity can 
be explained by the fact that biological treatment is not accessible 
for many patients in this country due to high costs (Fia & Westra, 
2018). Another limitation might be that the collecting and process-
ing techniques of GCF samples are sensitive, which should be taken 
into account (Lamster & Ahlo, 2007). Finally, we did not investigate 
the relationships between specific compositions of the subgingival 
microbial biofilm in this study but this will be investigated in our fu-
ture studies.
Within in the limitations of this study, the presence of IgA-ACPA 
and the absence of IgG ACPA in the GCF of HC point towards local 
induction of these autoantibodies. This local induction is probably, 
amongst others, related to chronic mucosal inflammation due to 
periodontal disease or smoking.
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